Renata Ferrarotto, Professor of Head and Neck Medical Oncology at MD Anderson Cancer Center, shared on LinkedIn:
“Grateful for the opportunity to present and discuss impactful clinical trials in head and neck cancer – including the practice-changing KEYNOTE-689 study – at the 2025 Best of ASCO in Minneapolis. A great exchange of ideas with colleagues committed to advancing care for our patients.”